Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5-a]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators

Author:

Wang Shuai1,Wang Sai-Qi2,Teng Qiu-Xu3,Yang Linlin4,Lei Zi-Ning3,Yuan Xiao-Han1,Huo Jun-Feng1,Chen Xiao-Bing2,Wang Mengru4,Yu Bin1ORCID,Chen Zhe-Sheng3ORCID,Liu Hong-Min1ORCID

Affiliation:

1. School of Pharmaceutical Sciences & Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou 450001, China

2. Department of Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Henan Cancer Institute, Zhengzhou 450008, China

3. College of Pharmacy and Health Sciences, St. John’s University, Queens, New York 11439, United States

4. Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China

Funder

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Program for Science & Technology Innovation Talents in Universities of Henan Province

1000 Talents Program of Central plains

Medical Science and Technique Foundation of Henan Province

Science and Technique Foundation of Henan Province

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3